{"retracted":false,"update":{"timestamp":1449014400000,"doi":"10.1007/s00277-015-2563-0","type":"correction"},"doi":"10.1007/s00277-015-2540-7","journal":"Annals of Hematology","publisher":"Springer Nature","title":"Erratum to: Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant"}
